Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Buy on IBEX, Lowers Price Target to $22-Report released on 8th February 2024

Author: Benzinga Newsdesk | February 09, 2024 05:54pm
Truist Securities analyst Tobey Sommer maintains IBEX (NASDAQ:IBEX) with a Buy and lowers the price target from $25 to $22.

Posted In: IBEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist